Your browser doesn't support javascript.
loading
Chronic lymphocytic leukaemia cells become both activated and immunosuppressive following interaction with CD3 and CD28 stimulated PBMC.
Hock, B D; Macpherson, S A; Fernyhough, L J; McKenzie, J L.
Afiliação
  • Hock BD; Haematology Research Group, Christchurch Hospital, Christchurch, New Zealand; Pathology Department, University of Otago, Christchurch, New Zealand. Electronic address: barry.hock@otago.ac.nz.
  • Macpherson SA; Haematology Department, Christchurch Hospital, Christchurch, New Zealand; Pathology Department, University of Otago, Christchurch, New Zealand.
  • Fernyhough LJ; Haematology Department, Christchurch Hospital, Christchurch, New Zealand; Pathology Department, University of Otago, Christchurch, New Zealand.
  • McKenzie JL; Haematology Research Group, Christchurch Hospital, Christchurch, New Zealand; Pathology Department, University of Otago, Christchurch, New Zealand.
Leuk Res ; 38(10): 1217-23, 2014 Oct.
Article em En | MEDLINE | ID: mdl-24976339
Chronic lymphocytic leukaemia (CLL) is associated with immunosuppression. The activation of CLL cells induced by interaction with other cell types, particularly activated T-cells, within the tumour micro-environment is thought to be important for CLL progression. However it is unclear whether activated CLL cells (CLL(Act)) have immunosuppressive capacity. We report that co-culture of CLL cells with normal PBMC in the context of CD3/CD28 T-cell activation generates CLL(Act) with increased CD38 expression that are capable of suppressing the proliferative responses of both CD4+ and CD8+ T-cells. The suppression required cell contact but did not involve induction of T-cell apoptosis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ativação Linfocitária / Leucemia Linfocítica Crônica de Células B / Tolerância Imunológica Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ativação Linfocitária / Leucemia Linfocítica Crônica de Células B / Tolerância Imunológica Idioma: En Ano de publicação: 2014 Tipo de documento: Article